Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
CardiovascularTOPICALStandard

NYSTATIN AND TRIAMCINOLONE ACETONIDE

NYSTATIN; TRIAMCINOLONE ACETONIDE

Standard Dose
100,000 UNITS/GM;0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NYSTATIN AND TRIAMCINOLONE ACETONIDE is listed in Drugs@FDA under application 214181 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NYSTATIN; TRIAMCINOLONE ACETONIDE Form and strength CREAM;TOPICAL - 100,000 UNITS/GM;0.1% Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2022-07-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview NYSTATIN AND TRIAMCINOLONE ACETONIDE is listed in Drugs@FDA under application 214181 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NYSTATIN; TRIAMCINOLONE ACETONIDE Form and strength CREAM;TOPICAL - 100,000 UNITS/GM;0.1% Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2022-07-13 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.